| Symposium 1 | ||
|---|---|---|
| 09:00 ~ 11:00 | Community-associated MRSA infections | |
| S1-1 | Unique Evolution of CA-MRSA Clones Geoffrey Coombs, Murdoch University, Australia |
|
| S1-2 | CA-MRSA as a new nosocomial pathogen Doo-Ryeon Chung, Samsung Medical Center, Korea |
|
| S1-3 | A vaccine for Staphylococcus aureus? Robert Daum, The University of Chicago, useA |
|
| S1-4 | Treatment options for CA-MRSA infections Ian Gould, NHS Grampian, UK |
|
| Symposium 2 | ||
|---|---|---|
| 09:00 ~ 11:00 | Emerging viral infections and vaccines | |
| S2-1 | Recent highly pathogenic avian influenza outbreaks by H5N6 and H5N8 viruses and molecular risk assessment of mammalian pathogenicity Hyuk-Joon Kwon, Seoul National University, Korea |
|
| S2-2 | Virological and immunological responses in MERS patients Nam-Hyuk Cho, Seoul National University College of Medicine, Korea |
|
| S2-3 | Clinical, epidemiological, and virological aspects of SFTS in Japan: what we have learned and what we should do? Masayuki Saijo, National Institute of Infectious Diseases, Japan |
|
| S2-4 | Infectious Diseases in the 21st Century: A Battle Plan for Survival Michael Osterholm, University of Minnesota, USA |
|
| Symposium 3 | ||
|---|---|---|
| 09:00 ~ 11:00 | Colistin-resistant gram-negatives | |
| S3-1 | Colistin resistance in gram-negatives Po-Ren Hsueh, National Taiwan University Hospital, Chinese Taipei |
|
| S3-2 | Emergence of mcr-1 colistin resistance: a new story begins Eun-Jeong Yoon, Research Institute of Bacterial Resistance, Korea |
|
| S3-3 | What to use in the clinical practice? Yohei Doi, University of Pittsburgh, USA |
|
| S3-4 | Colistin resistance: is it preventable? Anucha Apisarnthanarak, Thammasat University Hospital, Thailand |
|
| Plenary Lecture 1 | |
|---|---|
| 11:10 ~ 11:50 | Telehealth: new and important ways to treat infections Franklin Cockerill, Analyte Health, USA |
| P1-1 | |
| Plenary Lecture 2 | |
|---|---|
| 11:50 ~ 12:30 | Vaccines against emerging infections: where are we? Jerome Kim, International Vaccine Institute |
| P2-1 | |
| Oral Presentation 1 | |
|---|---|
| 15:00 ~ 16:00 | (7 minutes presentation & 3 minutes Q&A) |
| O1-GP01 | A Multicenter Study of Clinical Features and Organisms Causing Community-Onset Cellulitis in Korea Seong Yeon Park, Korea |
| O1-GP02 | Prevalence and antimicrobial resistance of methicillin-resistant and susceptible Staphylococcus pseudintermedius (MRSP) isolated from dogs in veterinary hospitals in Korea ChanHee LEE, Korea |
| O1-GP03 | Minimum Inhibitory Concentration of Vancomycin to Methicillin Resistant Staphylococcus aureus (MRSA) isolated at a Tertiary Care Hospital in Sri Lanka Nilanthi Senanayake, SriLanka |
| O1-GP04 | Synergistic combination of antibiotics targeting identical subcellular structure with different mechanism to prevent antimicrobial resistance Ganjun Yuan, China (P.R.C) |
| O1-GP05 | THE ROLE OF TOLL-LIKE RECEPTORS IN PATHOGENESIS OF PNEUMOCOCCI OF VARIOUS SEROTYPES Navindra Kumari Palanisamy, Malaysia |
| O1-GP06 | Disease, serotypes and in-vitro antimicrobial susceptibilities of Streptococcus pneumoniae from hospitalized adult patients in Hong Kong, 2012 – 2014 Reema Subramanian, Hong Kong China |
| Oral Presentation 2 | |
|---|---|
| 15:00 ~ 16:00 | (7 minutes presentation & 3 minutes Q&A) |
| O2-GN01 | Evaluation of multi drug resistant E.coli isolates and the role of Polymyxin B in urinary tract infections Kalyan Koganti, India |
| O2-GN02 | Outbreak of Colistin-Resistant KPC-2 Carbapenemase-Producing Klebsiella pneunoniae in Medical Intensive Care Unit Se Ju Lee, Korea |
| O2-GN03 | Antimicrobial Susceptibility and Molecular Characterization of Acinetobacter baumannii in Malaysia Eng Hwa Wong, Malaysia |
| O2-GN04 | Temporal relationship between β-lactam and β-lactamase inhibitor combinations and Klebsiella pneumoniae resistance to piperacillin/tazobactam Sukhyun Ryu, Korea |
| O2-GN05 | Study for Monitoring Antimicrobial Resistance Trends (SMART) in Australia and New Zealand (ANZ), 2002-2016 Ivana Rapajic-Moran, Australia |
| O2-GN06 | Forecast of global antimicrobial resistance of Escherichia coli and Klebsiella pneumoniae in invasive isolates: a population weighted mixed linear mathematical model Gerardo Alvarez-Uria, India |
| Symposium 4 | ||
|---|---|---|
| 16:00 ~ 17:30 | Carbapenem-resistant Enterobacteriaceae | |
| S4-1 | Carbapenemases from KPC to NDM to OXA-48: diverse enzymes in diverse clones David Livermore, University of East Anglia, UK |
|
| S4-2 | Diagnostic challenges in detecting carbapenem resistance Kyungwon Lee, Yonsei University College of Medicine, Korea |
|
| S4-3 | Antimicrobial treatment; recommendation and options for carbapenem-resistant Enterobacteriaceae Ami Neuberger, Rambam Medical Center, Israel |
|
| Symposium 5 | ||
|---|---|---|
| 16:00 ~ 17:30 | One world, one health | |
| S5-1 | One Health lessons from investigation emerging viruses of bat origin Linfa Wang, Duke-NUS Medical School, Singapore |
|
| S5-2 | One health approaches to zoonotic diseases and AMR Yong Ho Park, Seoul National University, Korea |
|
| S5-3 | One health activities on Nipah in Bangladesh: a high risk country for zoonotic disease spillover to man John Clemens, International Center for Diarrhoeal Disease Research, Bangladesh (icddr,b), Bangladesh |
|
| Symposium 6 | ||
|---|---|---|
| 16:00 ~ 17:30 | Pediatric mycoplasmal infections | |
| S6-1 | Mycoplasma pneumoniae Infection in Children Cheng-Hsun Chiu, Chang Gung Children's Hospital, Chinese Taipei |
|
| S6-2 | Macrolide-resistant Mycoplasma pneumoniae pneumonia in children Eun Hwa Choi, Seoul National University College of Medicine, Korea |
|
| S6-3 | Management of severe mycoplasma infection: role of antibiotics and steroid Nancy Henry, Mayo Clinic, USA |
|